PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.07%
Revenue growth under 50% of QCOM's 5.99%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-6.06%
Negative gross profit growth while QCOM is at 4.87%. Joel Greenblatt would examine cost competitiveness or demand decline.
-10.44%
Negative EBIT growth while QCOM is at 1.35%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-10.44%
Negative operating income growth while QCOM is at 1.35%. Joel Greenblatt would press for urgent turnaround measures.
-4.25%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-4.44%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-2.27%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.21%
Share reduction while QCOM is at 0.56%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.72%
Reduced diluted shares while QCOM is at 2.29%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.46%
Dividend growth of 0.46% while QCOM is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
102.70%
Positive OCF growth while QCOM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
243.37%
Positive FCF growth while QCOM is negative. John Neff would see a strong competitive edge in net cash generation.
91.91%
Positive 10Y revenue/share CAGR while QCOM is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
76.29%
5Y revenue/share CAGR under 50% of QCOM's 191.40%. Michael Burry would suspect a significant competitive gap or product weakness.
17.50%
3Y revenue/share CAGR under 50% of QCOM's 104.26%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
123.71%
10Y OCF/share CAGR at 75-90% of QCOM's 152.03%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
171.96%
5Y OCF/share CAGR above 1.5x QCOM's 108.50%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-13.46%
Negative 3Y OCF/share CAGR while QCOM stands at 42.10%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
311.00%
Below 50% of QCOM's 991.01%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
66.06%
Below 50% of QCOM's 279.42%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
11.12%
Below 50% of QCOM's 34.15%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
100.48%
10Y equity/share CAGR above 1.5x QCOM's 26.38%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
16.45%
Below 50% of QCOM's 127.06%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
5.88%
Below 50% of QCOM's 61.75%. Michael Burry suspects a serious short-term disadvantage in building book value.
361.29%
Dividend/share CAGR of 361.29% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
366.79%
Dividend/share CAGR of 366.79% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
652488.96%
3Y dividend/share CAGR above 1.5x QCOM's 78.32%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-2.04%
Firm’s AR is declining while QCOM shows 25.96%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-4.60%
Inventory is declining while QCOM stands at 0.98%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.68%
Asset growth well under 50% of QCOM's 7.96%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.34%
Under 50% of QCOM's 8.11%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
3.89%
R&D growth drastically higher vs. QCOM's 7.78%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-8.88%
We cut SG&A while QCOM invests at 7.86%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.